All
Results: 709-720 of 66486

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti-PD-1 Agonist Antibody Discovered Through Collaborative Research With FBRI









